GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 88 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,229,000 | +66.3% | 141,280 | +0.7% | 0.01% | +66.7% |
| Q1 2016 | $739,000 | -29.2% | 140,280 | +4.2% | 0.00% | -25.0% |
| Q4 2015 | $1,044,000 | -0.8% | 134,589 | +0.7% | 0.00% | 0.0% |
| Q3 2015 | $1,052,000 | -12.6% | 133,611 | +0.6% | 0.00% | -20.0% |
| Q2 2015 | $1,203,000 | -30.2% | 132,800 | 0.0% | 0.01% | -28.6% |
| Q1 2015 | $1,724,000 | -12.8% | 132,800 | -8.6% | 0.01% | 0.0% |
| Q4 2014 | $1,978,000 | +42.6% | 145,337 | -6.0% | 0.01% | +40.0% |
| Q3 2014 | $1,387,000 | -19.0% | 154,637 | +22.2% | 0.01% | -16.7% |
| Q2 2014 | $1,712,000 | +135.2% | 126,537 | +72.8% | 0.01% | +100.0% |
| Q1 2014 | $728,000 | -32.3% | 73,247 | -9.3% | 0.00% | -25.0% |
| Q4 2013 | $1,075,000 | +9.6% | 80,747 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $981,000 | +37.8% | 80,747 | +17.2% | 0.00% | +33.3% |
| Q2 2013 | $712,000 | – | 68,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 500,000 | $6,765,000 | 5.83% |
| Gruss & Co., LLC | 200,000 | $2,706,000 | 3.07% |
| First Light Asset Management, LLC | 150,076 | $2,031,000 | 1.37% |
| Curi RMB Capital, LLC | 1,032,369 | $13,968,000 | 0.88% |
| Camber Capital Management LP | 908,100 | $12,287,000 | 0.80% |
| CADIAN CAPITAL MANAGEMENT, LP | 887,500 | $12,008,000 | 0.36% |
| PARNASSUS INVESTMENTS, LLC | 2,118,127 | $28,658,000 | 0.25% |
| Visium Asset Management, LP | 786,468 | $10,641,000 | 0.16% |
| PUTNAM INVESTMENTS LLC | 5,198,367 | $70,333,000 | 0.15% |
| Capital Impact Advisors, LLC | 13,933 | $189,000 | 0.14% |